| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, Wisconsin 53226, USA; Dali University, Dali, Yunnan 671000, P.R. China; School of Preclinical Medicine, Sun Yat-Sen University, Guangzhou, Guangdong 510080, P.R. China; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, P. R. China; Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
* To whom correspondence should be addressed. Email:
demin.wang{at}bcw.edu.
Phospholipase C
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
Phospholipase C
2 contributes to light chain gene activation and receptor editing
![]()
Abstract
2 (PLC
2) is critical for pre-B cell receptor (pre-BCR) and BCR signaling. Current studies discovered that PLC
2-deficient mice had reduced immunoglobulin (Ig)
light chain usage throughout B cell maturation stages, including transitional type 1 (T1), transitional type 2 (T2), and mature follicular B cells. The reduction of Ig
rearrangement by PLC
2 deficiency was not due to specifically increased apoptosis or decreased proliferation of mutant Ig
+ B cells, as lack of PLC
2 inflicted a similar effect on apoptosis and proliferation of both Ig
+ and Ig
+ B cells. Moreover, PLC
2-deficient IgHEL transgenic B cells exhibited an impairment of antigen-induced receptor editing among both the endogenous
and
loci in vitro and in vivo. Importantly, PLC
2 deficiency impaired BCR-induced expression of IRF-4 and IRF-8, the two transcription factors critical for
and
light chain rearrangements. Taken together, these data demonstrate that PLC
2 signaling pathway plays a role in activation of light chain loci and contributes to receptor editing.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|